Trial intelligence / Profile preview

Tolerability of Two Oxalate Products for Dentinal Hypersensitivity

NCT02613117Completed

Sponsor
Procter & Gamble
Start
Nov 2015
Primary completion
Jun 2016
Countries
1
01

Overview

Open-label trial in Dentinal hypersensitivity (DH) (2 arms), sponsored by Procter & Gamble. Primary endpoints: How Satisfied Were Participants With Treatment? at 8 weeks, Ease of Treatment at Home at 8 weeks and 1 more. Started Nov 2015; status: completed.

02

Conditions

Dentinal hypersensitivity (DH)

Beyond the preview

Go deeper on NCT02613117.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02613117.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call